Sleeping giant: Ambien's PR sloth.

The article discusses the response of drug marketer Sanofi-Aventis to mass media's tales of consumers driving and binge eating while still asleep and under the influence of Ambien, a drug for the treatment of insomnia. Despite damning reports in media the company hasn't changed its advertising and has issued only curt statements addressing the reports that Ambien is showing up as a factor in drivers who take the medication and have no memory of getting behind the wheel, and that it's the cause of a rare disorder known as sleep-eating.